Organizers:
Jose Lutzky, MD, FACP – Mount Sinai Comprehensive Cancer Center
Sigrun Hallmeyer, MD – Advocate Lutheran General Hospital
Jeanelle King, PA-C – Mount Sinai Comprehensive Cancer Center
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE- and CNE-certified programs.
When: 8:00 AM to 2:00 PM (ET) on March 10, 2018
Where: Miami Marriott Biscayne Bay
1633 N Bayshore Dr., Miami, FL, 33132
This program has already taken place, to find information on upcoming programs, please check here.
SITC members are eligible for discounted registration rates. To receive discounted member rates, your membership dues must be current through 2017.
Click here to learn more about the registration rates for members and non-members for these programs.
This program is presented in collaboration with the American Academy of Emergency Medicine (AAEM) and the Association of Community Cancer Centers (ACCC).
The 2017 Advances in Cancer Immunotherapy™ series is supported in part by independent medical educational grants from Aduro Biotech, Inc., Amgen, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Incyte Corporation, Merck & Co., Inc. and Prometheus Laboratories Inc.
#ClinicalTrials #CNE #Clinician #Collaboration #SkinCancers #PresentationSlides #Vaccines #InPersonEvent #Toxicities
#AlliedHealth #Industry #Immunomodulators #CombinationTherapy #LungCancers #HeadandNeckCancers #Pharmacist #Nurse #SITC #2017 #Oncologist #ImmuneCheckpointInhibitors #Adverse Events
#AdvancesinCancerImmunotherapy(ACI) #HematologicMalignancies #CollaborativeEvent #Biomarkers #Introductory
#CME #GenitourinaryCancers